Rubius Therapeutics Long Term Debt Current 2011-2026 | RUBY

Annual Long Term Debt Current Rubius Therapeutics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.1 M	9.02 M	8.94 M	10.5 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
10.5 M	1.1 M	7.4 M

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer	Long Term Debt Current	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	1.59 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	5.67 M	-	-	$ 86.2 M	USA
MorphoSys AG MOR	3.63 M	-	2.43 %	$ 254 M	Germany
Alterity Therapeutics Limited ATHE	57.6 K	$ 3.83	2.56 %	$ 9.21 B	Australia
Akouos AKUS	671 K	-	0.23 %	$ 488 M	USA
Alnylam Pharmaceuticals ALNY	45.5 M	$ 327.43	-1.79 %	$ 42.9 B	USA
Applied Molecular Transport AMTI	4.64 M	-	-	$ 10.1 M	USA
I-Mab IMAB	8.06 M	-	-	$ 866 M	China
AlloVir ALVR	316 K	-	4.14 %	$ 49.1 M	USA
Aligos Therapeutics ALGS	3.58 M	$ 8.4	13.24 %	$ 83 M	USA
Allakos ALLK	3.25 M	-	-	$ 28.6 M	USA
Ayala Pharmaceuticals AYLA	419 K	-	-	$ 7.46 M	Israel
Applied Therapeutics APLT	429 K	-	-	$ 8.42 M	USA
Aptinyx APTX	337 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	2.2 M	-	-13.39 %	$ 1.45 M	USA
Brainstorm Cell Therapeutics BCLI	208 K	-	-2.5 %	$ 5.88 M	USA
Amphastar Pharmaceuticals AMPH	7.93 M	$ 21.7	0.09 %	$ 1.01 B	USA
CymaBay Therapeutics CBAY	7 K	-	-	$ 3.45 B	USA
Cabaletta Bio CABA	3.46 M	$ 3.46	1.62 %	$ 348 M	USA
BioNTech SE BNTX	45 M	$ 100.8	1.34 %	$ 27.2 B	Germany
Advaxis ADXS	166 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	215 K	-	5.93 %	$ 314 M	Canada
Can-Fite BioPharma Ltd. CANF	43 K	$ 3.1	-2.36 %	$ 5.1 M	Israel
AgeX Therapeutics AGE	181 K	-	-10.17 %	$ 12.2 K	USA
ContraFect Corporation CFRX	671 K	-	-5.16 %	$ 5.39 M	USA
Aeglea BioTherapeutics AGLE	625 K	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	3.55 M	$ 1.4	-9.68 %	$ 360 M	USA
Applied Genetic Technologies Corporation AGTC	1.27 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	631 K	$ 4.18	-1.3 %	$ 447 M	USA
Arcutis Biotherapeutics ARQT	294 K	$ 24.21	-1.51 %	$ 3.08 B	USA
AIkido Pharma AIKI	554 K	-	1.93 %	$ 17.4 M	USA
Autolus Therapeutics plc AUTL	4.56 M	$ 1.51	1.36 %	$ 402 M	Britain
Aptose Biosciences APTO	193 K	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	20.7 M	-	0.49 %	$ 251 B	Cayman-islands
Caladrius Biosciences CLBS	137 K	-	-16.75 %	$ 25.8 M	USA
AVROBIO AVRO	878 K	-	1083.1 %	$ 745 M	USA
Clearside Biomedical CLSD	364 K	-	-	$ 25.3 M	USA
Celldex Therapeutics CLDX	1.55 M	$ 33.59	-0.82 %	$ 2.23 B	USA
bluebird bio BLUE	21.2 M	-	-	$ 546 M	USA
AstraZeneca PLC AZN	382 M	-	-	$ 96.9 B	Britain